CHICAGO (GenomeWeb) – A new pan-cancer analysis suggests that there may be a benefit to doing germline testing for Lynch syndrome in advanced cancer patients who have high microsatellite instability (MSI) in their tumors.
CHICAGO (GenomeWeb) – A new pan-cancer analysis suggests that there may be a benefit to doing germline testing for Lynch syndrome in advanced cancer patients who have high microsatellite instability (MSI) in their tumors.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.